The Global Leader in Wire-Free Localization is taking the precision of SCOUT to a new dimension: SCOUT MD™ receives FDA Clearance!

The Global Leader in Wire-Free Localization is taking the precision of SCOUT to a new dimension: SCOUT MD™ receives FDA Clearance!

The most widely adopted, clinically referenced wire-free platform transforms surgical localization with SCOUT MD™.  Four distinct Reflector shapes and signals support:

  • Precise tumor margin mapping (circumferential localization)

  • Localizing multiple lesions in the breast, multiple nodes

  • Unique reflector shapes that further support time of biopsy localization

The Nasdaq Tower in Times Square congratulated Merit on our FDA 510(K) clearance for SCOUT MD™. We couldn’t be prouder of our teams who made this possible.

The tremendous news about SCOUT MD™ coincides with another important milestone for Merit! Over 500,000 patients have been treated with SCOUT® Radar Localization.  We are honored to have helped make a difference in so many patients’ lives worldwide. We want to thank the physicians who partner with us with the shared goal of a better patient experience


Merit Partners with the Society of Surgical Oncology (SSO) to Offer a Premiere Industry Webinar! “Innovations in Cancer Care: State of the Art Approaches for Tumor and Node Localization”

Join SSO experts in breast and surgical oncology as they discuss employing advanced applications of SCOUT® Radar localization to include reflector placement at the time of biopsy, prior to neoadjuvant chemotherapy and under MRI guidance to minimize delays in surgical treatment. Discussion includes how placement of multiple reflectors supports precision in tumor margin mapping, and the novel use of RADAR localization for Melanoma Metastases and other soft tissue tumors.

Register Here - March 6th, 7pm EST

To view or add a comment, sign in

Explore content categories